quinapril has been researched along with Disease Models, Animal in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 8 (28.57) | 18.2507 |
| 2000's | 17 (60.71) | 29.6817 |
| 2010's | 2 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchinoue, S; Ishii, Y; Kubota, K; Nakajima, I; Sawada, T; Teraoka, S | 1 |
| Allen, TJ; Cooper, ME; de Gasparo, M; Feng, B; Jandeleit-Dahm, KA; Li, J; Schumacher, C; Thomas, MC; Watson, AM | 1 |
| Bauer, WR; Hiller, KH; Kraus, G; Ruile, P; Waller, C | 1 |
| Blanco, J; Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Ruperez, M | 1 |
| Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
| Fuchinoue, S; Ishii, Y; Nakajima, I; Sawada, T; Teraoka, S; Tojimbara, T | 1 |
| Adamek-Guzik, T; Korbut, R; Korbut, RA; Madej, J | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Tachikawa, H; Takahashi, T; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Blanco, S; Egido, J; Gómez-Guerrero, C; López, D; Romero, R; Vaquero, M | 1 |
| Dalbeth, N; Hall, FC | 1 |
| Boomsma, F; Buikema, H; de Zeeuw, D; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Buczko, W; Chabielska, E; Domaniewski, T; Karp, A; Kramkowski, K; Malinowska-Zaprzałka, M; Mogielnicki, A; Opadczuk, A; Wojewódzka-Zelezniakowicz, M | 1 |
| Akashiba, A; Honda, T; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Ohta, S; Ono, H; Takahashi, M; Takahashi, T; Yoshii, M | 1 |
| Egido, J; Gállego-Delgado, J; Lázaro, A; Osende, JI; Vivanco, F | 1 |
| Brower, GL; Janicki, JS; Levick, SP | 1 |
| Boucher, DM; Cohen, DM; Kaplan, HR; Olszewski, BJ; Ryan, MJ; Singer, RM; Smith, RD | 1 |
| Plosker, GL; Sorkin, EM | 1 |
| Aoki, K; Nakajima, T; Setoguchi, M; Yaoka, O | 1 |
| Bizollon, CA; Gharib, C; Lantelme, P; Lo, M; Mullins, JJ; Sassard, J | 1 |
| Dai, E; Liu, LY; Lucas, A; Nation, PN | 1 |
| Bustos, C; Egido, J; Hernández-Presa, MA; Ortega, L; Ortego, M; Tuñón, J | 1 |
| Bastien, N; Lambert, C | 1 |
| Hori, M; Hoshida, S; Kawahara, K; Kuzuya, T; Yamashita, N | 1 |
| Cachofeiro, V; Lahera, V; Maeso, R; Navarro-Cid, J; Rodrigo, E; Ruilope, LM | 1 |
| Rupp, H; Turcani, M | 1 |
| Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Glantz, SA; Parmley, WW; Pulukurthy, S; Sudhir, K; Sun, YP; Zhu, BQ | 1 |
| Baigorria, ST; García, NH; Juncos, LI | 1 |
| Dienesch, C; Horn, M; Hügel, S; Neubauer, S; Remkes, H | 1 |
2 review(s) available for quinapril and Disease Models, Animal
| Article | Year |
|---|---|
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Models, Animal; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney; Male; Quinapril; Tetrahydroisoquinolines | 1994 |
Effect of treatment on survival in an animal model of chronic heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cricetinae; Disease Models, Animal; Heart Failure; Humans; Isoquinolines; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines | 1998 |
1 trial(s) available for quinapril and Disease Models, Animal
| Article | Year |
|---|---|
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Models, Animal; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney; Male; Quinapril; Tetrahydroisoquinolines | 1994 |
26 other study(ies) available for quinapril and Disease Models, Animal
| Article | Year |
|---|---|
An experimental model of encapsulating peritoneal sclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Kidney Failure, Chronic; Mice; Mice, Inbred C57BL; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Diseases; Peritoneum; Prognosis; Quinapril; Sclerosis; Tetrahydroisoquinolines | 2009 |
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Function Tests; Mice; Mice, Knockout; Pyridines; Pyrimidines; Quinapril; Tetrahydroisoquinolines | 2010 |
Tissue ACE inhibition improves microcirculation in remote myocardium after coronary stenosis: MR imaging study in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Female; Fibrosis; Hemodynamics; Magnetic Resonance Imaging, Cine; Microcirculation; Myocardial Perfusion Imaging; Myocardium; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Recovery of Function; Tetrahydroisoquinolines; Time Factors; Ventricular Function, Left | 2010 |
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Chemokines; Cytokines; Disease Models, Animal; Female; Immune Complex Diseases; Inflammation Mediators; Infusion Pumps; Infusions, Parenteral; Kidney; Mesangial Cells; Nephritis; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Isoquinolines; Mice; Mice, Inbred C57BL; Quinapril; Retroperitoneal Fibrosis; Sclerosis; Tetrahydroisoquinolines | 2002 |
Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Bradykinin; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Erythrocyte Aggregation; Hypertension; Indomethacin; Injections, Intraperitoneal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2003 |
Comparative effects of quinapril with enalapril in rats with heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Fibrosis; Male; Myocardium; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Pressure | 2004 |
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunoenzyme Techniques; Kidney; Kidney Glomerulus; Linear Models; Microscopy, Electron; Obesity; Pyrroles; Quinapril; Rats; Rats, Zucker; Staining and Labeling; Tetrahydroisoquinolines | 2005 |
Angiotensin receptor blockers ameliorate collagen-induced arthritis in mice: comment on the article by Sagawa et al.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arthritis, Experimental; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Collagen Type II; Disease Models, Animal; Imidazoles; Joints; Male; Mice; Mice, Inbred DBA; Olmesartan Medoxomil; Ovalbumin; Quinapril; T-Lymphocytes; Tetrahydroisoquinolines; Tetrazoles | 2005 |
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination; Follow-Up Studies; Hydrochlorothiazide; Male; Myocardial Infarction; Quinapril; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Pressure | 2005 |
Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Disease Models, Animal; Enalapril; Fibrillar Collagens; Fibrin; Hemostasis; Male; Perindopril; Platelet Adhesiveness; Platelet Aggregation; Quinapril; Rats; Rats, Wistar; Regional Blood Flow; Tetrahydroisoquinolines; Thromboembolism | 2006 |
Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Models, Animal; Heart Rate; Heart Ventricles; Hypertension; Kidney; Kidney Diseases; Male; Nitrendipine; Organ Size; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Time Factors | 2006 |
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach.
Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Heart; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Myocardium; Proteomics; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines | 2007 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Indoles; Isoquinolines; Kinetics; Male; Quinapril; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrahydroisoquinolines | 1984 |
[Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hypertension; Hypertension, Renal; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Wistar; Tetrahydroisoquinolines | 1993 |
Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Isoquinolines; Losartan; Male; Natriuresis; Quinapril; Rats; Tetrahydroisoquinolines; Tetrazoles | 1996 |
Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Chickens; Cholesterol; Disease Models, Animal; Herpesvirus 2, Gallid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isoquinolines; Lymphocytes; Marek Disease; Pravastatin; Quinapril; Tetrahydroisoquinolines | 1998 |
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Arteriosclerosis; Chemokine CCL2; Cholesterol; Collagen; Disease Models, Animal; Immunohistochemistry; In Situ Hybridization; Interleukin-8; Isoquinolines; Macrophages; NF-kappa B; Platelet-Derived Growth Factor; Quinapril; Rabbits; Tetrahydroisoquinolines | 1998 |
Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arterial Occlusive Diseases; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Isoquinolines; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; P-Selectin; Peroxidase; Quinapril; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Ventricular Fibrillation | 1999 |
Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Diltiazem; Disease Models, Animal; Endothelium, Vascular; Hypertension; Isoquinolines; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation; Vasodilator Agents | 1999 |
Heart failure development in rats with ascending aortic constriction and angiotensin-converting enzyme inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Cardiac Output, Low; Collagen; Disease Models, Animal; Hydroxyproline; Isoquinolines; Male; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Treatment Outcome; Vasoconstriction | 2000 |
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Captopril; Cholesterol; Disease Models, Animal; Isoquinolines; Kinins; Losartan; Male; Nitric Oxide; Quinapril; Rabbits; Receptors, Angiotensin; Tetrahydroisoquinolines; Vasoconstriction; Vasodilation | 2001 |
Hyperkalemia, renal failure, and converting-enzyme inhibition: an overrated connection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Disease Models, Animal; Female; Glomerular Filtration Rate; Humans; Hyperkalemia; Hypertension, Renal; Isoquinolines; Kidney; Male; Middle Aged; Nephrectomy; Peptidyl-Dipeptidase A; Potassium; Quinapril; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Retrospective Studies; Tetrahydroisoquinolines; Uremia | 2001 |
Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatine Kinase; Disease Models, Animal; Energy Metabolism; Heart Failure; Isoquinolines; Magnetic Resonance Spectroscopy; Myocardial Infarction; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Remodeling | 2001 |